Cite Filings / DYN / 0000950170-24-002276
Feed Companies Filings Check
Sign in
144

Sale of Securities

Dyne Therapeutics, Inc. · Filed 2024-01-04 · Acc 0000950170-24-002276

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2024-01-26 144 Sale of Securities
  • 2024-01-04 4 CEO & President sold 269,719 shares at an average $18.66 ($5,032,915)
  • 2024-01-04 4 Chief Scientific Officer sold 87,779 shares at an average $18.57 ($1,629,985)
  • 2024-01-04 4 Chief Business Officer sold 31,900 shares at an average $16.59 ($529,194)
  • 2024-01-04 4 SVP, Head of Finance & Admin. sold 13,000 shares at $18.81 ($244,530)
  • 2024-01-04 144 Sale of Securities
  • 2024-01-04 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…